Centessa Pharmaceuticals plcCC

Centessa Pharmaceuticals plc

14.59USDR
+0.08+0.55%
At close at Mar 28, 22:04 GMT
USD
No trades
See on Supercharts

CNTA fundamentals

Key facts

Market capitalization‪1.94 B‬USD
Basic EPS (TTM)−1.99USD
Founded2020
CEOSaurabh Saha
About

Centessa Pharmaceuticals Plc operates as clinical-stage pharmaceutical company, which engages in discovering and developing medicines that delivers transformational to patients. Its portfolio include preclinical to phase three uncorrelated programs spanning diseases with high unmet need across oncology, hematology, immunology, inflammation, neuroscience, and rare diseases. The company was founded on October 26, 2020 and is headquartered in Altrincham, the United Kingdom.

Ownership
‪‪132.63 M‬‬
Free Float shares
‪‪80.34 M‬‬ (60.57%)
Closely held shares
‪‪52.29 M‬‬ (39.43%)
Free Float shares
‪‪80.34 M‬‬ (60.57%)
Closely held shares
‪‪52.29 M‬‬ (39.43%)
Capital structure
Market cap
‪‪1.94 B‬‬
Debt
‪‪117.23 M‬‬
Cash & equivalents
‪‪482.18 M‬‬
Enterprise value
‪‪1.57 B‬‬

Valuation

Fundamental metrics to determine fair value of the stock

Summary
‪‪1.94 B‬‬
Price to earning ratio (P/E)
Price to sales ratio (P/S)
Market Cap
Net income
Revenue
Price to earning ratio (P/E)
Price to sales ratio (P/S)
Valuation ratios
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
‪0.00‬
‪70.00‬
‪140.00‬
‪210.00‬
‪280.00‬
P/S

Growth and Profitability

Company’s recent performance and margins

Performance
‪−540%‬
‪−530%‬
‪−520%‬
‪−510%‬
‪−500%‬
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
‪‪−120.00 M‬‬
‪‪−80.00 M‬‬
‪‪−40.00 M‬‬
‪0.00‬
‪‪40.00 M‬‬
Revenue
Net income
Net margin %
Revenue to profit conversion
Revenue
COGS
Gross profit
Op expenses
Op income
Non-Op income/ expenses
Taxes & Other
Net income
‪‪−120.00 M‬‬
‪‪−90.00 M‬‬
‪‪−60.00 M‬‬
‪‪−30.00 M‬‬
‪0.00‬
Revenue
COGS
Gross profit
Expenses & adjustments
Net income
‪‪−120.00 M‬‬
‪‪−90.00 M‬‬
‪‪−60.00 M‬‬
‪‪−30.00 M‬‬
‪0.00‬

Revenue breakdown

Revenue streams and regions a business earns money from

By source/business
Period: 2024
Pharmaceutical
By country
Period: 2024
United Kingdom

Estimates

Revenue and Earnings forecasts and estimates accuracy

Revenue
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
‪0.00‬
Actual
Estimate
Earnings
Next:May 19, 2025
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
‪−0.84‬
‪−0.63‬
‪−0.42‬
‪−0.21‬
‪0.00‬
Actual
Estimate

Dividends

Dividend yield, history and sustainability

CNTA does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future

Financial health

Financial position and solvency of the company

Debt level and coverage
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
‪‪−150.00 M‬‬
‪0.00‬
‪‪150.00 M‬‬
‪‪300.00 M‬‬
‪‪450.00 M‬‬
Debt
Free cash flow
Cash & equivalents
Financial position analysis
Short term
Long term
‪0.00‬
‪‪150.00 M‬‬
‪‪300.00 M‬‬
‪‪450.00 M‬‬
‪‪600.00 M‬‬
Assets
Liabilities